| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 05/03/1997 | CA2189222A1 Alkylxanthine phosphonates and alkylxanthine phosphine oxides and their use as pharmaceuticals |
| 05/02/1997 | EP0770622A2 Cyclic adhesion inhibitors |
| 05/02/1997 | EP0770613A1 Substituted Imidazolidin-2,4-dione der4ivatives as immunomodulators |
| 05/02/1997 | EP0770612A1 Terazosin crystalline polymorph and pharmaceutical compositions thereof |
| 05/02/1997 | EP0770602A2 Crystals of piperidine derivatives, intermediates for production of the same, and process for producing the same |
| 05/02/1997 | EP0770395A1 Use of botulinum toxins for treating headache |
| 05/02/1997 | EP0770392A2 Use of salts of lanthanide, tin, zinc, manganese, yttrium, cobalt, strontium in a pharmaceutical composition |
| 05/02/1997 | EP0770385A1 Use of astaxanthin for the treatment of stress |
| 05/02/1997 | EP0770133A1 Adenovirus comprising a gene coding for an no synthase |
| 05/02/1997 | EP0770087A1 Human elastase iv |
| 05/02/1997 | EP0770081A1 Heterocycle-condensed morphinoid derivatives |
| 05/02/1997 | EP0770066A1 Serotonin 5-ht 1a and dopamin d2 receptor ligands |
| 05/02/1997 | EP0770059A1 Substituted benzamidines, their production and their use as medicaments |
| 05/02/1997 | EP0770058A1 Novel chemical compound, its preparation and use as a drug |
| 05/02/1997 | EP0769961A1 Attenuation of wound healing processes |
| 05/02/1997 | EP0769947A1 Indolinone compounds for the treatment of disease |
| 05/02/1997 | EP0769941A1 Use of droloxifene for the treatment of prostatic diseases, endometriosis and obesity |
| 05/02/1997 | EP0769940A1 INDENE sPLA 2? INHIBITORS |
| 05/02/1997 | EP0769903A1 Inducible nitric oxide synthase gene for treatment of disease |
| 05/02/1997 | EP0707571B1 3,5-dioxo-(2h,4h)-1,2,4-triazine derivatives as 5ht1a ligands |
| 05/01/1997 | WO1997015572A1 Lubeluzole n-oxide |
| 05/01/1997 | WO1997015570A1 Novel acid pyrazole derivatives, preparation method therefor, use thereof as drugs, novel use therefor, and pharmaceutical compositions containing such derivatives |
| 05/01/1997 | WO1997015567A1 5-membered heterocycles, pharmaceutical agents containing said compounds and the use thereof and methods of producing them |
| 05/01/1997 | WO1997015556A1 3-spiro-indolin-2-one derivatives as vasopressin and/or oxytocin receptor ligands |
| 05/01/1997 | WO1997015315A1 Localized intravascular delivery of tfpi for inhibition of restenosis in recanalized blood vessels |
| 05/01/1997 | WO1997015312A1 Nitrogen monoxide composition for use as a drug |
| 05/01/1997 | WO1997015311A1 Nitrogen monoxide composition for use as a drug |
| 05/01/1997 | WO1997015306A1 Infusions of neuroprotectants and perfluorochemicals |
| 05/01/1997 | WO1997015302A1 Pharmaceutical compositions of levo-enantiomers of medetomidine derivatives and their use |
| 05/01/1997 | CA2232336A1 Pharmaceutical compositions of levo-enantiomers of medetomidine derivatives and their use |
| 05/01/1997 | CA2229617A1 5-membered heterocycles, medicaments containing these compounds, their use and processes for their preparation |
| 05/01/1997 | CA2228054A1 Lubeluzole n-oxide |
| 05/01/1997 | CA2188381A1 Glycomimetics as selectin antagonists and pharmaceuticals having antiin flammatory activity |
| 04/30/1997 | CN1148843A Enhancement of the effect of drugs by deuteration |
| 04/30/1997 | CN1148811A Compound having antihypertensive, cardioprotective, anti-ischemic and antilipolytic functions |
| 04/30/1997 | CN1148807A Pyrimidine ortriazine carboxylic acid derivatives to be used as medicaments |
| 04/30/1997 | CN1148594A Piperidyl methyl oxazolidinone |
| 04/30/1997 | CN1148590A Sulfuryl or sulfinyl benzoyl guanidine derivative |
| 04/30/1997 | CN1148499A Medicine for reducing blood-pressure and preparation method thereof |
| 04/30/1997 | CN1148492A Treatment for arteriosclerosis and vitiligoidea |
| 04/30/1997 | CN1034732C Quinuclidine derivative for treatment of inflammatory and gastrointestinal disorders |
| 04/29/1997 | US5625067 Cyclopentane ether derivatives, processes for their production, and their pharmaceutical use |
| 04/29/1997 | US5624961 Benzylaminoethoxybenzene derivatives, production thereof and use thereof |
| 04/29/1997 | US5624953 Pharmaceutical compounds |
| 04/29/1997 | US5624952 Vasoconstrictors |
| 04/29/1997 | US5624949 Protein kinase C inhibitors |
| 04/29/1997 | US5624944 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[cd]indoles |
| 04/29/1997 | US5624941 Pyrazole derivatives, method of preparing them and pharmaceutical compositions in which they are present |
| 04/29/1997 | US5624923 Tricyclic diazepine vasopressin antagonists and oxytocin antagonists |
| 04/29/1997 | US5624921 Hypotriglyceridemic aminoacetylmercapto derivatives |
| 04/29/1997 | US5624685 High polymer gel and vascular lesion embolizing material comprising the same |
| 04/29/1997 | US5624672 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof |
| 04/28/1997 | CA2188908A1 Substituted 2,4-imidazolidinedione compounds as pharmaceutical active ingredients |
| 04/28/1997 | CA2188901A1 Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases |
| 04/24/1997 | WO1997014716A1 Cyclopeptide derivatives |
| 04/24/1997 | WO1997014432A1 Modulation of integrin-mediated signal transduction |
| 04/24/1997 | WO1997014307A1 Method for treating ischemic tissue |
| 04/24/1997 | WO1997009348A3 Orphan receptor |
| 04/24/1997 | DE19538741A1 Cyclopeptidderivate Cyclopeptide derivatives |
| 04/24/1997 | CA2207973A1 Modulation of integrin-mediated signal transduction |
| 04/23/1997 | EP0769007A1 2-ureido-benzamide derivatives |
| 04/23/1997 | EP0769005A2 Pla 2? inhibitors and their use for inhibition of intestinal cholesterol absorption |
| 04/23/1997 | EP0768891A1 Use of insulin and igf-i |
| 04/23/1997 | EP0768878A1 Endothelin receptor antagonists |
| 04/23/1997 | EP0656844B1 Crank mechanism for a windscreen wiper drive of a motor vehicle |
| 04/23/1997 | EP0651754B1 K-252a DERIVATIVES |
| 04/23/1997 | EP0621869B1 Human kunitz-type protease inhibitor variants |
| 04/23/1997 | CN1148393A Bradykinin antagonist peptides incorporating N-substituted glycines |
| 04/23/1997 | CN1148340A Method for treating 5HT2B receptor related conditions |
| 04/23/1997 | CN1148337A Compound active at a novel site on receptor-operated calcium channels usefull for treatment of neurological disorders and diseases |
| 04/23/1997 | CN1147937A Use of sertraline to treat post myocardial infraction patients |
| 04/23/1997 | CN1034662C Process for preparing tetrazde devivatives |
| 04/22/1997 | US5622992 Administering topical aromatic releasing decongestant composition to treat nasal symptoms |
| 04/22/1997 | US5622989 Amino-benzofuryl-and thienyl-derivatives |
| 04/22/1997 | US5622987 Prevent migration or proliferation of smooth muscle cells |
| 04/22/1997 | US5622985 Method for preventing a second heart attack employing an HMG CoA reductase inhibitor |
| 04/22/1997 | US5622975 Prophylaxis or treatment of cardiovascular disorders such as atherosclerosis, restenosis, inflammation, or malignant invasion |
| 04/22/1997 | US5622965 4-hydroxy-3-nitro-1,2-dihydroquinolin-2-ones and the use thereof as excitatory amino acid and glycine receptor antagonists |
| 04/22/1997 | US5622952 Glycine receptor antagonists and the use thereof |
| 04/22/1997 | US5622701 Provides monoclonal antibodies that have binding site that specifically binds to p-selectin and to e-selectin |
| 04/21/1997 | CA2188238A1 Injectable gaseous no/co2 composition |
| 04/17/1997 | WO1997013854A1 Pilosulin 2 |
| 04/17/1997 | WO1997013771A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 04/17/1997 | WO1997013764A1 Lipophilic benzothiophenes |
| 04/17/1997 | WO1997013758A1 Pyridazinones as endothelin-receptor antagonists |
| 04/17/1997 | WO1997013757A1 Pyrazolone derivatives |
| 04/17/1997 | WO1997013744A1 3-amino-propoxyphenyl derivatives (i) |
| 04/17/1997 | WO1997013513A1 At1-receptor antagonists for preventing and treating postischemic renal failure and for protecting ischemic kidneys |
| 04/17/1997 | WO1997013511A1 Methods of inhibiting plasminogen activator inhibitor 1 |
| 04/17/1997 | WO1997013506A1 η-RAR ANTAGONIST LIGAND OR α-RAR AGONIST LIGAND AS AN APOPTOSIS INHIBITOR |
| 04/17/1997 | WO1997013504A1 Pharmaceutical compositions containing hydroximic acid derivatives |
| 04/17/1997 | WO1997013501A1 Liposomal compositions and methods of using them |
| 04/17/1997 | CA2234560A1 Pyrazolones |
| 04/17/1997 | CA2234404A1 Methods of inhibiting plasminogen activator inhibitor 1 |
| 04/17/1997 | CA2234267A1 Lipophilic benzothiophenes |
| 04/17/1997 | CA2232231A1 Pilosulin 2 |
| 04/17/1997 | CA2231547A1 Liposomal compositions and methods of using them |
| 04/17/1997 | CA2207243A1 Endothelin receptor antagonists |
| 04/17/1997 | CA2187850A1 Physiologically active ei-1941 compounds |
| 04/16/1997 | EP0768379A1 Ubiquitous potassium-channel proteins and genes for the same |